| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/05/2011 | CA2366255C Symmetric, monofunctionalised polymethine dyes labelling reagents |
| 04/05/2011 | CA2349043C System and method for analyzing antibiotic susceptibility of biological samples |
| 04/05/2011 | CA2322895C Spectrophotometric and nephelometric detection unit |
| 04/05/2011 | CA2321474C Sperm analysis system |
| 04/05/2011 | CA2267795C Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation |
| 04/05/2011 | CA2261562C Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 04/02/2011 | CA2716259A1 Multi-analyte test strip with inline working electrodes and shared opposing counter/reference electrode |
| 03/31/2011 | WO2011038301A2 Screening methods |
| 03/31/2011 | WO2011038228A1 Bent nanowires and related probing of species |
| 03/31/2011 | WO2011038158A2 Methods, compositions, systems and apparatus for molecular array fabrication |
| 03/31/2011 | WO2011038142A2 Bladder cancer specific ligand peptides |
| 03/31/2011 | WO2011038138A1 Protein arrays and uses thereof |
| 03/31/2011 | WO2011038063A1 Method of diagnosing and treating interstitial cystitis |
| 03/31/2011 | WO2011037990A1 Entangled mate sequencing |
| 03/31/2011 | WO2011037916A1 Method leukemia diagnosis using caspase-3 |
| 03/31/2011 | WO2011037702A1 Amperometric creatinine biosensor with immobilized enzyme-polymer composition and systems using same, and methods |
| 03/31/2011 | WO2011037643A2 Compositions and methods for detecting and treating prostate carcinoma |
| 03/31/2011 | WO2011037622A1 Cancer treatment using selective photo-apoptosis |
| 03/31/2011 | WO2011037533A1 Sers device |
| 03/31/2011 | WO2011037485A1 Preparation of restriction endonucleases in ivcs using fret and facs selection |
| 03/31/2011 | WO2011037480A1 System and method for verifying type and quality of alcoholic beverages |
| 03/31/2011 | WO2011037371A9 Portable blood analysis apparatus |
| 03/31/2011 | WO2011037371A2 Portable blood analysis apparatus |
| 03/31/2011 | WO2011037348A2 Microorganism analyzer, and analysis method using same |
| 03/31/2011 | WO2011037306A1 Detection of target nucleic acid sequences by cyclic exonucleolytic reactions |
| 03/31/2011 | WO2011037262A1 Hybridoma producing anti-methylated dna antibody and utilization of same |
| 03/31/2011 | WO2011037196A1 Screening method for transcriptional control element of lacritin gene |
| 03/31/2011 | WO2011037045A1 Method for determination of renal cell carcinoma |
| 03/31/2011 | WO2011036878A1 Amelioration of metabolic syndrome or method for screening for ameliorating agent for metabolic syndrome utilizing physiological function of sphingomyelin synthase sms2 |
| 03/31/2011 | WO2011036638A1 Substance determining apparatus |
| 03/31/2011 | WO2011036597A1 Binding assay with multiple magnetically labelled tracer binding agents. |
| 03/31/2011 | WO2011036589A1 Method for characterization of biological bonds |
| 03/31/2011 | WO2011036565A2 Device for detecting gases and/or volatile organic compounds (voc) |
| 03/31/2011 | WO2011036563A2 Structure of the n-rna complex of the non-segmented negative-strand rna viruses of the paramyxoviridae family |
| 03/31/2011 | WO2011036476A1 Affinity capillary electrophoresis method for assessing a biological interraction of a ligand/receptor pair such as g protein coupled receptor and its targets as well as for drug screening |
| 03/31/2011 | WO2011036453A1 Methods of analysing homeostatic state in cell systems |
| 03/31/2011 | WO2011036450A2 Splice variants |
| 03/31/2011 | WO2011036440A1 Antagonists of dsg2 for treatment of cancer |
| 03/31/2011 | WO2011036429A1 Detection of risk of pre-eclampsia |
| 03/31/2011 | WO2011036378A1 Method for detecting molecules through mass spectrometry |
| 03/31/2011 | WO2011036342A1 Portable moisture meter |
| 03/31/2011 | WO2011036329A1 Improved method for assessing cardiovascular risk |
| 03/31/2011 | WO2011036319A1 Method for producing biomimetic electrodes and the uses thereof as amperometric sensors |
| 03/31/2011 | WO2011036308A1 Method for preclinical testing of immunomodulatory drugs |
| 03/31/2011 | WO2011036292A1 Method for the automated preparation of samples for a biosensor system and device for carrying out said method |
| 03/31/2011 | WO2011036267A2 Serum infrared spectroscopy for non invasive assessment of hepatic fibrosis in patients with chronic liver disease |
| 03/31/2011 | WO2011036256A1 Methods for predicting the responsiveness of a patient affected with a tumor to a treatment with a tyrosine kinase inhibitor |
| 03/31/2011 | WO2011036220A1 Immunodiffusion assay for influenza virus |
| 03/31/2011 | WO2011036139A1 Method for the extraction and detection of fat-soluble components from biological materials |
| 03/31/2011 | WO2011036118A1 Treating cancer by modulating mex-3 |
| 03/31/2011 | WO2011036117A1 Method for the diagnosis of non-alcoholic steatohepatitis based on a metabolomic profile |
| 03/31/2011 | WO2011035959A1 Process analysis unit |
| 03/31/2011 | WO2011035922A2 Inhibitors of fgf2 phosphorylation and their use for treating angiogenesis-related diseases |
| 03/31/2011 | WO2011035904A1 A combination of markers for predicting the mortality risk in a polytraumatized patient |
| 03/31/2011 | WO2011035861A1 Stack of test strips and method for the production thereof |
| 03/31/2011 | WO2011035818A1 Method and apparatus for carrying out hardness tests on tablets |
| 03/31/2011 | WO2011035759A1 Method for examining the reactivity of an electronic sensor with a comparison medium as part of a test routine |
| 03/31/2011 | WO2011035433A1 Selected strains on serum-free growth media for proteomics analysis of lung cancer biomarkers |
| 03/31/2011 | WO2011035391A1 Method of contaminant prediction |
| 03/31/2011 | WO2011035385A1 Testing device for identifying antigens and antibodies in biofluids |
| 03/31/2011 | WO2011014282A3 High magnification spectral reflectance biosensing with discrete light sources |
| 03/31/2011 | WO2011012811A3 Novel peptidase substrates |
| 03/31/2011 | WO2011012809A3 Novel peptidase substrates |
| 03/31/2011 | WO2011012646A3 Non-invasive in vivo optical imaging method |
| 03/31/2011 | WO2011010870A9 Genetic marker for predicting the survival of a patient with early-stage lung cancer, and method for predicting survival using same |
| 03/31/2011 | WO2011006909A3 Marker sequences for adiposity |
| 03/31/2011 | WO2011002845A3 System for estimating a gas concentration in a mixed atmosphere |
| 03/31/2011 | WO2011002779A3 Methods and apparatuses for applying and removing fluids for processing biological samples |
| 03/31/2011 | WO2011001123A3 Functionalization of sp3 hybridized carbon, silicon, and/or germanium surfaces |
| 03/31/2011 | WO2010150013A3 Identification of sex-linked proteins |
| 03/31/2011 | WO2010148332A3 Systems and methods for analyzing a particulate |
| 03/31/2011 | WO2010147958A3 Robot for orchestrating microfluidics experiments |
| 03/31/2011 | WO2010138843A3 Acute lymphoblastic leukemia (all) biomarkers |
| 03/31/2011 | WO2010132479A3 Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 03/31/2011 | WO2010132459A3 Biomarkers for assessment of age-related macular degeneration |
| 03/31/2011 | WO2010132453A3 Methods and compositions for analyte detection |
| 03/31/2011 | WO2010129787A3 Single molecule spectroscopy for analysis of cell-free nucleic acid biomarkers |
| 03/31/2011 | WO2010129656A3 Method of oligonucleotide labeling using cycloaddition reaction |
| 03/31/2011 | WO2010129386A3 Method for binding site identification by molecular dynamics simulation (silcs: site identification by ligand competitive saturation) |
| 03/31/2011 | WO2010127114A3 Automated detection and counting of biomolecules using nanoparticle probes |
| 03/31/2011 | WO2010124256A3 Methods and systems for identifying immunomodulatory substances |
| 03/31/2011 | WO2010124240A3 Bin1 as a prognostic marker in cardiovascular disease |
| 03/31/2011 | WO2010121174A3 Chemiluminescent enzyme assay method and compounds |
| 03/31/2011 | WO2010120509A3 Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities |
| 03/31/2011 | WO2010118411A3 Improved methods for conducting assays |
| 03/31/2011 | WO2010117470A3 Nanopore sequencing devices and methods |
| 03/31/2011 | WO2010117456A9 Column enrichment of pcr beads comprising tethered amplicons |
| 03/31/2011 | WO2010115167A3 Methods and devices for sorting cells and other biological particulates |
| 03/31/2011 | WO2010111691A3 Conjugates of biomolecules to nanoparticles |
| 03/31/2011 | WO2010111656A3 Systems and methods for assessing images |
| 03/31/2011 | WO2010111360A3 Diagnosis of ciliopathies |
| 03/31/2011 | WO2010111299A3 Synthetic antibodies |
| 03/31/2011 | WO2010091264A3 Simultaneous detection of estrogen and non estrogen steroids |
| 03/31/2011 | WO2010091021A8 Oligomer sequences mapping |
| 03/31/2011 | WO2010088650A3 Biomarker signature to predict cancer treatment response |
| 03/31/2011 | US20110077930 Computer-implemented method for providing a personalized tool for estimating 1,5-anhydroglucitol |
| 03/31/2011 | US20110077908 Method for Diagnosing the Functional Reliability of a Lambda Probe |
| 03/31/2011 | US20110077871 Analysis apparatus, information processing unit, and an information displaying method |
| 03/31/2011 | US20110077869 Circuit for detecting analytes via nanoparticle-labeled substances with electromagnetic read-write heads |
| 03/31/2011 | US20110077415 UV Excitable Fluorescent Energy Transfer Dyes |